CL

Business profile & competitive position

Colgate-Palmolive Company (CL) is classified as a Consumer Defensive stock in the Household & Personal Products industry. Its operations are organized into two segments: Oral, Personal and Home Care, and Hill’s Pet Nutrition. Products include toothpaste, toothbrushes, soaps, deodorants, skin-health products, household cleaners, fabric conditioners, and specialty dog and cat foods. According to the company’s most recent 10-K, Oral Care accounted for 44% of worldwide net sales in 2025, Pet Nutrition for 23%, Personal Care for 17%, and Home Care for 16%.

The company sells in more than 200 countries and territories through retailers, wholesalers, e-commerce platforms, veterinarians, and select direct-to-consumer channels. Walmart and its affiliates represented approximately 11% of 2025 net sales; no other customer exceeded 10%. As of December 31, 2025, Colgate-Palmolive employed about 33,600 people across more than 100 countries, with over 84% located outside the United States.

The financial metrics create a nuanced picture of competitive strength. Net margin is 9.7%, which is solid but not unusually wide for a branded consumer-staples business. ROE is reported at 631.1%, an extreme figure that is mathematically possible when equity is small relative to net income, often due to leverage, share buybacks, or accounting effects. Without detailed balance-sheet data, the elevated ROE should be read as a reason to examine capital structure rather than as proof of exceptional operating dominance. The beta of 0.32 confirms the defensive, low-volatility nature of the business.

Financial posture

Colgate-Palmolive currently carries a market capitalization of $68.9 billion and trades at a P/E of 33.8. That is a premium valuation for a consumer-staples company, suggesting the market is pricing in stability, resilient cash generation, and dependable earnings. At the current snapshot, the stock trades at $86.06, below its 50-day exponential moving average of $89.22, with an RSI of 38.6.

The 9.7% net margin supports the P/E only if earnings growth and cash-flow generation remain steady; any margin compression would make the 33.8 multiple look even richer. The beta of 0.32 implies very low sensitivity to broader equity-market swings, a hallmark of defensive consumer names. Again, the 631.1% ROE is best viewed as a signal to dig into leverage and equity levels, not as standalone evidence of widening competitive moats.

Strategic priorities & outlook

The company’s most recent 10-K outlines four interconnected priorities. First, it aims to drive organic sales growth and deliver consistent, compounded earnings-per-share growth. Second, it plans to achieve operational efficiencies while growing free cash flow and using the balance sheet efficiently. Third, it intends to leverage global brand reach, science-based innovation, an agile supply chain, and best-in-class omni-channel demand generation. Fourth, it is building capabilities in data, analytics, and artificial intelligence while cultivating an inclusive culture.

Hill’s Pet Nutrition, at 23% of 2025 sales, fits the “science-based innovation” pillar well, as premium pet food increasingly competes on clinical nutrition and veterinary endorsement. The Oral Care segment, at 44% of sales, remains the core revenue engine and is likely the focus of the omni-channel and AI-driven marketing efforts. The emphasis on organic growth rather than large acquisitions suggests management is counting on pricing power, product mix, and volume gains within existing categories.

Macro & geopolitical exposure

As a global Household & Personal Products company, Colgate-Palmolive faces macro and geopolitical exposures tied to its international footprint and commodity-linked cost base. With operations spanning more than 200 countries and over 84% of employees located outside the U.S., foreign-exchange movements are a constant factor. A stronger U.S. dollar reduces the translated value of overseas revenue, while currency weakness in key emerging markets can limit pricing flexibility.

Input costs also matter. Toothpaste, soaps, cleaners, and fabric conditioners depend on petrochemical derivatives, surfactants, palm-oil-related inputs, plastic packaging, and freight. Volatility in oil, agricultural commodities, or shipping can pressure margins even when companies pass through price increases. Regulatory exposure is real as well: product-safety, labeling, and environmental standards affect personal-care and household-cleaning products across multiple jurisdictions. Trade policy is another consideration, since tariffs on raw materials, packaging, or finished goods can shift supply-chain economics for a multinational manufacturer.

Recent developments

The latest headlines have focused on Colgate-Palmolive’s income and growth profile rather than operational disruptions. On September 27, 2026, 247wallst.com published “Colgate-Palmolive Has Paid a Dividend Since 1895. Does That Streak Still Deserves Your Money?,” framing the stock around its dividend history. On September 24, 2026, fool.com included CL in “3 Dividend Stocks to Buy and Hold Even if the Fed Keeps Raising Interest Rates,” underscoring its perceived defensiveness in a higher-rate environment.

On September 23, 2026, zacks.com ran “Here’s Why Colgate-Palmolive (CL) is a Strong Growth Stock,” and PR Newswire announced that “Tom’s of Maine Introduces Hydroxyapatite Toothpaste to Meet Rising Consumer Demand.” The Tom’s of Maine launch is relevant to the Oral Care segment that generated 44% of 2025 net sales, and hydroxyapatite toothpaste is one of the faster-growing niches in oral care. Taken together, the news flow shows investor attention split between the company’s cash-return characteristics and modest innovation-driven growth in core categories.

Earnings behavior & post-earnings drift

Colgate-Palmolive has beaten earnings estimates in every quarter of the last eight reported, for a beat rate of 8/8 (100%). The average earnings surprise across those quarters is 3.3%, meaning the company consistently exceeds the official consensus by a modest, predictable margin rather than with large upside shocks.

The four most recent quarters, listed from most recent to oldest, were reported on July 31, 2026; May 1, 2026; January 30, 2026; and October 31, 2025. On July 31, 2026, CL reported EPS of $0.99 versus an estimate of $0.947, a 4.5% surprise; the stock fell 1.56% the next day but recovered 2.16% over the following five sessions. On May 1, 2026, actual EPS was $0.97 versus $0.943 estimated, a 2.9% surprise; the next-day reaction was −2.17%, with only a 0.33% five-day drift. On January 30, 2026, actual EPS of $0.95 beat the $0.912 estimate by 4.2%, and the stock gained 1.77% the next day plus 4.56% over the next five days. On October 31, 2025, EPS of $0.91 beat the $0.889 estimate by 2.4%, yet the stock dropped 2.69% the next day before drifting up 2.22% over five days.

Over the full eight-quarter history, the average five-day price move after earnings is 2.32%, classified as an upward post-earnings drift. That upward drift exists despite negative next-day reactions in three of the last four reports, suggesting the market has often initially sold or shrugged off the news, only for the stock to recover in the following week. The next scheduled earnings report is October 30, 2026, before the market open, with the current consensus EPS estimate at $0.92.